Bosh sahifaMRK • NYSE
add
Merck & Co Inc
80,93 $
Seans yopilganidan keyin:(0,086%)+0,070
81,00 $
Yopilgan:3-iyl, 15:55:30 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
82,39 $
Kunlik diapazon
80,70 $ - 82,81 $
Yillik diapazon
73,31 $ - 129,93 $
Bozor kapitalizatsiyasi
203,22 mlrd USD
Oʻrtacha hajm
16,61 mln
Narx/foyda
11,78
Dividend daromadliligi
4,00%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 15,53 mlrd | -1,56% |
Joriy xarajat | 5,92 mlrd | 4,83% |
Sof foyda | 5,08 mlrd | 6,66% |
Sof foyda marjasi | 32,71 | 8,35% |
Har bir ulushga tushum | 2,22 | 7,25% |
EBITDA | 7,28 mlrd | -4,45% |
Amaldagi soliq stavkasi | 13,86% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 9,23 mlrd | 64,23% |
Jami aktivlari | 115,12 mlrd | 8,76% |
Jami passivlari | 66,72 mlrd | 1,98% |
Umumiy kapital | 48,40 mlrd | — |
Tarqatilgan aksiyalar | 2,51 mlrd | — |
Narxi/balansdagi bahosi | 4,29 | — |
Aktivlardan daromad | 13,39% | — |
Kapitaldan daromad | 18,53% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 5,08 mlrd | 6,66% |
Operatsiyalardan naqd pul | 2,50 mlrd | -19,09% |
Sarmoyadan naqd pul | -1,49 mlrd | -8,07% |
Moliyadan naqd pul | -5,76 mlrd | -104,51% |
Naqd pulning sof oʻzgarishi | -4,59 mlrd | -270,44% |
Boʻsh pul | 760,50 mln | -48,11% |
Haqida
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Tashkil etilgan
1-yan, 1891
Sayt
Xodimlar soni
74 000
